The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

President Donald Trump's executive order aims to eliminate private-sector middlemen from U.S. drug price negotiations, ...

Walgreens aims to free up time for pharmacy staff, reducing their routine tasks and eliminating inventory waste.

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

The global ambulatory infusion center market is estimated to be valued USD 52.19 Bn in 2025 and is expected to reach USD 107.07 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.8% ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

Ameriprise Financial gave CVS Health a hefty financial vitamin boost, upping its stake by 9.6% and now holding shares worth ...

CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...